点击了解更多+
Contact Us/ CONTACT US
Service Hotline
Building 57, No. 128, Bridge Road, Kangqiao Town, Pudong New Area, Shanghai
Shanghai Kaibao Pharmaceutical Co., Ltd.
Classification: Customer Case
Classification: Successful Cases
Time：2017-10-13 13:03
Shanghai Kaibao Pharmaceutical Co., Ltd. was incorporated in the Bay Tourist Area on April 12, 2000. Kaibao Pharmaceutical's leading product with independent intellectual property rights, Tanreqing Injection, a national class II new drug, was authorized by the State Intellectual Property Office on December 15, 2000, with the patent number ZL 94103391.0. The drug is the first batch of traditional Chinese medicine injections produced according to the fingerprint of the Chinese Pharmacopoeia. The injection has achieved new breakthroughs in the efficacy, safety and stability of antipyretic and expectorant, anti-inflammatory and antiviral. In 2008, the sales volume accounted for 22% of the national antipyretic and detoxifying injections.
Shanghai Kaibao Pharmaceutical Co., Ltd. was incorporated in the Bay Tourist Area on April 12, 2000. Kaibao Pharmaceutical's leading product with independent intellectual property rights, Tanreqing Injection, a national class II new drug, was authorized by the State Intellectual Property Office on December 15, 2000, with the patent number ZL 94103391.0. The drug is the first batch of traditional Chinese medicine injections produced according to the fingerprint of the Chinese Pharmacopoeia. The injection has made new breakthroughs in the efficacy, safety and stability of antipyretic, expectorant, anti-inflammatory and antiviral injections. In 2008, the sales volume accounted for 22.2 of the national antipyretic and detoxifying injections.
